Abstract-An americium solution injected intramuscularly into several nonhuman primates (NHPs) was found to behave differently than predicted by the wound models described in the NCRP Report 156. This was because the injection was made along with a citrate solution, which is known to be more soluble than chlorides, oxides, or nitrates on which the NCRP Report was based. A multiexponential wound model specific to the injected americium solution was developed based on the retention in the intramuscular sites. The model was coupled with the americium systemic model to interpret the urinary excretion data and assess the intake, and it was determined that the models were adequate to predict early urinary excretion in most cases but unable to predict late urinary excretion. This was attributed to the differences in the systemic handling of americium between humans and nonhuman primates. Information on the type of wounds, solubility, particle size, mass, chemical form, etc., should always be considered when performing wound dosimetry. Health Phys. 112(6): 544-549; 2017 
INTRODUCTION
RADIOACTIVE MATERIALS can enter the human body through various pathways, including inhalation, ingestion, injection, wounds, or transdermal absorption. The intake of radioactive materials via wounds is a significant pathway of occupational intake, especially for actinides-the work conducted at Hanford, Rocky Flats, and other U.S. Department of Energy facilities has resulted in a large number of radionuclide contaminated wounds, with more than 2,100 total cases reported in the scientific literature (NCRP 2007) . The biokinetics of radioactive materials deposited in a contaminated wound site is significantly different than that of ingested or inhaled radioactive materials (Guilmette and Durbin 2003) , and as such, different models are necessary to describe the biokinetics of radioactive materials. The National Council on Radiation Protection and Measurements (NCRP) published Report No. 156 as the first consensus biokinetic model to describe the wound behavior of radioactive materials (NCRP 2007) . The NCRP wound model, which represents a relatively recent addition to the current family of biokinetic models developed for various types of intakes, was heavily based on data from the animal experiments. The authors of the NCRP Report No. 156 acknowledged this limitation and encouraged the application of the model to actual occupational data involving radionuclide contamination in wounds for further validation (Guilmette et al. 2007) . Am) is one of the most common radionuclides involved in occupational wound cases owing to the nuclear weapons research and developmental works in the United States (NCRP 2007) . However, most documented occupational exposures typically involve medical treatments such as chelation therapy or surgical excision of contaminated tissue and/or are confounded by other forms of intake such as inhalation (NCRP 2007) . The biokinetic data from unperturbed human wound exposures may thus be inadequate to develop or validate the wound models. In such cases, experimental animal data can be used to validate or improve biokinetic models. In fact, the data from experimental nonhuman primates (NHP) studies have been successfully used in the past to better understand the biokinetic behavior of a radionuclide wound intake (Allen et al. 2016; Poudel et al. 2016a) .
The purpose of this study was to use the wound retention and urinary excretion data from the NHPs intramuscularly injected with americium solution in relation to the predictions of the NCRP 156 wound model coupled with the ICRP 67 systemic model for americium. The NHP data (Durbin et al. 1990a and b) were made available through the Lawrence Berkeley National Laboratory (LBNL) to R. A. Guilmette as a bequest from P. W. Durbin.
EXPERIMENTAL DATA
In the interval 1960 to 1985, P.W. Durbin and her colleagues collected bioassay and autopsy data from several NHPs intramuscularly or intravenously injected with americium with an objective of supplementing the scarce data available on the biokinetics of americium in the body. Since it is reasonable to assume that intramuscular injections simulate deep puncture wounds (NCRP 2007) , the interest of this study is focused on several male and female Cynomolgus (Macaca fasicularis) and Rhesus (M. arctoides) macaques that were given an intramuscular injection of 241 Am(III) with various dosages (Table 1) .
The injections were prepared from a stock solution of 241 Am(NO 3 ) 3 that was obtained from the Actinide Chemistry Group at LBL. The solution was stored at 4°C until the time for injection, at which time different volumes of the solution were withdrawn and diluted with isotonic sodium citrate. The desired volumes or masses of the solution were then injected into the animal intramuscularly in the thickest part of the thighs. Urine samples from the animals were collected at frequent intervals from the day of injection to the death. At the time of death, the amount of americium remaining at the site of the wound was also measured (Durbin et al. 1990a and b) .
RETENTION IN WOUNDS
The NCRP 156 wound model is a multi-compartmental biokinetic model capable of describing the behavior of both soluble and insoluble radioactive materials regardless of the initial physical and chemical state. The category "soluble" is further divided into retention classes of weak, moderate, strong, and avid categories depending on their solubility, whereas particulate radionuclides have been grouped into colloid, particle, or fragment categories based on their physical properties and retention pattern. First-order kinetics are used to describe the transfer of material from one compartment to another, and the suggested transfer rates are given in NCRP 156 (NCRP 2007) .
NCRP Report No. 156 also proposes a multi-exponential equation to represent the average retention behavior of a radioactive material in a wound; i.e.,
where R(t) is the radionuclide retention at the wound site (fraction of injected activity), A i and l i are the partition coefficient and retention rate constant for retention component i, and t is days after deposition. The default coefficients for two-or three-component exponential equations for different classes of radionuclides are given in NCRP Report No. 156 and are reproduced in Table 2 (NCRP 2007) . The retention at the injection sites of the NHPs was compared against the retention in the wound sites predicted by the default wound models for soluble radionuclides (Fig. 1a) . The retention behavior of the given americium solution a few days post intake is described better by the wound model for weakly-retained radionuclides, whereas the behavior between approximately 20 to 200 d typically falls in between the predictions of the models for weakly-and moderately-retained radionuclides. Similarly, the retention The urinary excretion data and wound retention data on this case was not available. The retention in wounds for these cases were reported as '0% of the injected activity'. several months (>200 d) post intake is modeled better as a moderately-retained radionuclide (Fig. 1a) . The NCRP Report (NCRP 2007) places trivalent americium-241 [ 241 Am(III)] as a strongly retained radionuclide within the NCRP 156 solubility structure; however, the actual retentions in the intramuscular (i.m.) sites for the experimental animals were not accurately described by the wound model for the strongly retained radionuclides. In fact, it is apparent that none of the wound models can accurately describe the retention behavior of the given americium solution. It is to be noted that the wound models for soluble radionuclides derived in NCRP 156 were heavily based on data from rodents injected with oxides, chlorides, and nitrates (NCRP 2007) , with the americium data derived from studies that used 241 AmCl 3 (e.g., Scott et al. 1948 ) and 241 Am(NO 3 ) 3 (e.g., Harrison et al. 1978) . It has been established that the rate of absorption from the wound is strongly dependent on the chemistry and solubility of a compound with complex compounds such as citrates and oxalates absorbed faster into the blood than oxides, nitrates or chlorides (Ilyin 2001) . Moreover, the solubility and thus the biokinetics of a radionuclide were found to be affected when the radionuclide was injected in citrate solution (e.g., Taylor 1962; Poudel et al. 2016b ). Thus, the inability of the default NCRP 156 wound models to predict the retention in the wounds can be attributed to the difference in biokinetics caused by the injection of americium nitrate along with the sodium citrate solution. These results necessitate a new model to accurately describe the behavior of the given radioactive solution.
The retention functions for wounds have been historically determined empirically through a tedious and time consuming iterative process. Such processes involve starting with a set of preliminary parameters that typically includes a short-term and long-term retention compartment, and making manual iterative adjustments to the assumed wound retention parameters until the "best-fit" to the data (evaluated quantitatively using chi-square, or qualitatively "by eye") is obtained. Instead of manual iterations, a software program OriginPro® (version 9.1) was used to fit the wound retention data to the following multi-exponential equation:
The constraints were set for fitting such that the sum of the amplitudes is one, and the fitting algorithm was run for a maximum of 5,000 iterations. The equation that fits the retention data the best was found to be eqn (3), with an R 2 of 0.63. An addition of a third compartment did not result in an improved fit. Therefore, the following model was considered the final retention model: 
MAXIMUM LIKELIHOOD ANALYSIS OF URINARY EXCRETION DATA
The wound model can be coupled with a systemic model such that the input to the blood compartment of the wound model is the input to the transfer compartment of the systemic model (NCRP 2007) . The wound model described above can be combined with an americium systemic model to interpret the urinary excretion data and assess the intake. The currently recommended biokinetic and dosimetric model for americium is described in ICRP Publication 67 (ICRP 1993) . The blood compartment in the systemic model is connected to soft tissues, skeleton, liver, kidneys, and the urinary bladder, each of which is represented by one or more compartments. Transfer between the compartments is characterized by first order kinetics; the default transfer rates for americium are given in ICRP Publication 67.
Coupling the wound model with a systemic model requires the consideration of the transfer of activity away from both the wound site and the lymph nodes. The default parameters given in Table 2 are accurate for cases in which significant transfer of radionuclides to the lymph nodes does not occur. In cases where such transfer occurs (for example, the particulate material), the parameters will overestimate the absorption to the blood and hence the urinary excretion rate. For americium injected in a citrate solution, the subject of this discussion, significant transfer to the lymph nodes is rarely the case. Therefore, the wound model obtained above can be coupled with the systemic model to analyze the urinary excretion data.
Internal dosimetry software Integrated Modules for Bioassay Analysis (IMBA) (Birchall et al. 2007 ) Professional Plus (version 4.1.58) was used to analyze the urinary excretion data collected from the nonhuman primates. The software uses the maximum likelihood method (James 2005) to calculate intake I from a set of bioassay measurements. In addition to the bioassay data, the input to the IMBA code requires the uncertainty of each bioassay data point and an assumption about the error associated with each data point. According to the IDEAS guidelines (Castellani et al. 2013 ), the overall uncertainty on an individual measurement can be described in terms of a lognormal distribution, and the scattering factor (SF) is defined as its geometric standard deviation. The maximum likelihood method minimizes the value of chi-square, which is given as:
and the estimate of the intake is given as (Castellani et al. 2013 ):
where M i is the value of the ith measurement, m(t i ) is the intake retention fraction or excretion fraction associated with the ith measurement, I i is the intake calculated from the ith measurement and is given as I i = M i /m(t i ), and SF i is the scattering factor associated with the ith measurement. The IDEAS guidelines (Castellani et al. 2013 ) suggest an SF of 1.6 for simulated 24-h urine samples.
The results of the maximum likelihood analysis of the urinary data using the customized wound model and the ICRP 67 americium model are given in Table 3 and Fig. 2 . Acceptable fits (p-value > 0.05) were obtained for 13 of the 20 cases. The ratios of the intake predicted using the maximum likelihood analysis of urine data to the actual intake ranged from 0.58 to 4.30 with an average of 1.44 ± 0.94 (1 standard deviation). When the cases for which the maximum likelihood analysis yielded unacceptable fits were excluded, the ratio was 1.14 ± 0.37. The data from none of the cases sacrificed past 336 d post-intake yielded acceptable fits, which can be attributed to the differences in the systemic handling of actinides between humans and NHPs several months post-intake. In particular, the differences are:
(1) shorter retention in liver and skeleton of NHPs, (2) differences in liver to bone partitioning, and (3) higher excretion through the liver-biliary-fecal pathway in NHPs (Poudel et al. 2016b and c) . It is to be noted that the maximum likelihood analysis of urinary excretion data from macaques intramuscularly injected with plutonium citrate also yielded similar results-the ICRP 67 Pu systemic model was unable to explain the urinary excretion rates more than 200 d postintake (Poudel et al. 2016a ).
CONCLUSION
These results indicate that the behavior of americium nitrate (injected with sodium citrate) in simulated wounds in the NHPs is different than the behavior predicted by the default retention parameters in the NCRP 156 wound model. This was expected because of the increased solubility of the citrate solution. A multi-exponential wound model was developed based on the wound retention data. The model was then coupled with the systemic model for americium to analyze the urinary excretion data, and it was determined that the models were capable of predicting the early urinary excretion of americium in NHPs, with a few exceptions. For some cases, the predicted intake was more than four times the actual intake. The late urinary excretion data could not be explained because of the differences in the systemic behavior of americium in humans and nonhuman primates.
It should be noted that the wound model developed in this paper was based on the data from intramuscular injections (deep puncture wounds) and may not accurately represent the behavior in other types of wounds. The types of wounds incurred by the subjects play a significant role in the absorption rate of the radioactive material. In addition, the actual solubility and thus the retention of the material in wounds have possibly been impacted by introduction of radioactive material into the wounds along with the sodium citrate solution. Therefore, information on solubility, particle size, mass, chemical form, etc., should always be taken into consideration before performing wound dosimetry, as the wound biokinetics may be significantly impacted by those physical factors.
